Ketamine for PTSD is emerging as one of the more promising developments in mental health treatment in recent years, drawing serious attention from researchers and clinicians alike.
It works differently than anything that came before it, and for many people, it can bring relief that felt out of reach for years.
What is PTSD and why is it hard to treat?
Post-traumatic stress disorder (PTSD) is a mental health condition that affects approximately 13 million adults in the US in any given year. It can develop after experiencing or witnessing a deeply distressing event, such as combat, sexual assault, a serious accident, or the sudden loss of someone close. It’s not a sign of weakness or an inability to cope. It’s a change in how the brain processes threat, memory, and safety.
Symptoms typically fall into four categories: re-experiencing the trauma (flashbacks, nightmares), avoidance of reminders, negative shifts in mood and thinking, and heightened reactivity (hypervigilance, irritability, difficulty sleeping). For many people, these symptoms are relentless and interfere with every part of daily life.
First-line treatments, including cognitive processing therapy (CPT), prolonged exposure therapy, and SSRI medications, help many people.
But a meaningful portion of those with PTSD don’t respond adequately, or find that symptoms return over time. This is sometimes called treatment-resistant PTSD. For these individuals, finding the right path forward often means looking beyond the standard playbook.
How does ketamine for PTSD work?
Most psychiatric medications target serotonin, a neurotransmitter involved in mood regulation. SSRIs like sertraline and paroxetine (the only two FDA-approved medications for PTSD) follow this approach. Ketamine takes an entirely different path.
Ketamine works primarily on the glutamate system, the brain’s main excitatory signaling network. It blocks a receptor called NMDA (N-methyl-D-aspartate), which triggers a rapid surge in glutamate activity. This cascade appears to promote neuroplasticity, the brain’s ability to form new connections, in regions involved in mood, memory, and emotional regulation.
For people with PTSD, this matters for a specific reason. Traumatic memories are stored differently than ordinary memories. They can become “stuck,” replaying with intense emotional charge because the brain’s threat-detection system, particularly the amygdala, remains in a state of high alert.
Ketamine may help disrupt this cycle by supporting a process called fear memory reconsolidation, essentially creating a window in which traumatic memories can be revisited with less emotional reactivity.
In a landmark randomized controlled trial published in JAMA Psychiatry, researchers found that a single infusion of ketamine produced rapid and significant reductions in PTSD symptom severity compared to placebo. Effects were seen within 24 hours.
The speed of that response — hours rather than weeks — is part of what makes ketamine so clinically interesting for PTSD treatment.
What does the research say?
The evidence base for ketamine and PTSD is still growing, but what exists is encouraging. Multiple studies have found that ketamine can produce rapid, meaningful reductions in core PTSD symptoms, including intrusive memories, hyperarousal, and emotional numbing, often within hours of a single dose.
Research also suggests that repeated ketamine treatments may extend and deepen those benefits. Some patients report improvements lasting weeks after a full treatment series, particularly when combined with psychotherapy to help integrate the experience.
That said, it’s important to be clear about where the science stands: most ketamine PTSD studies to date have been relatively small, and longer-term data is still limited. Researchers are actively working to better understand optimal dosing, frequency, and which patients are most likely to benefit. Ketamine is not a cure, and results vary from person to person.
What the research does support is that ketamine for PTSD treatment represents a genuinely different mechanism of action, one that may reach people who haven’t responded to anything else.
Is ketamine FDA-approved for PTSD?
No. Ketamine is not FDA-approved for PTSD. When ketamine is used for psychiatric conditions, including PTSD, it is considered off-label use. Off-label means a medication is prescribed for a purpose other than what the FDA specifically reviewed and approved it for. This is legal and common in psychiatry. Many medications are routinely used off-label when clinical evidence supports their use.
Spravato® (esketamine), a nasal spray closely related to ketamine, is FDA-approved, but specifically for treatment-resistant depression (TRD) and for major depressive disorder with suicidal thoughts or actions. It is not currently FDA-approved for PTSD.
This distinction matters practically. Because ketamine for PTSD is off-label, insurance coverage is less predictable than it would be for an approved indication. It’s worth discussing coverage directly with your provider and insurance plan before beginning treatment.
Ketamine for PTSD at Pacific Mind Health
At Pacific Mind Health, ketamine therapy is available for patients who haven’t found adequate relief through standard treatments. The practice offers intranasal and sublingual ketamine, administered and monitored in a clinical setting by an experienced care team.
Each session includes a two-hour monitoring period following the dose, during which a clinician monitors your response. Some patients experience mild dissociation, a dreamlike or slightly detached feeling, during treatment. This is expected and typically resolves within the same visit.
Treatment generally follows an induction phase (more frequent sessions in the early weeks), followed by an optimization phase and a maintenance schedule tailored to your response. The goal is not just symptom reduction during treatment, but building toward more lasting stability.
Transcranial magnetic stimulation (TMS) is also available at Pacific Mind Health for patients with PTSD. TMS is a non-invasive, FDA-cleared treatment that uses targeted magnetic pulses to stimulate underactive brain regions involved in mood regulation.
For some patients, TMS and ketamine may be considered together as part of a comprehensive treatment plan, something your provider can discuss with you during a consultation.
What to expect and who is a good candidate?
The first step is a psychiatric evaluation to determine whether ketamine therapy is appropriate for you. Your provider will review your history, current symptoms, previous treatments, and any medical considerations that could affect candidacy.
Ketamine is generally considered for people who have tried at least one or two standard treatments (medication, therapy, or both) without sufficient relief.
People with complex PTSD (C-PTSD), a pattern of symptoms that develops after prolonged or repeated trauma, such as childhood abuse or domestic violence, may also be candidates for ketamine therapy.
While C-PTSD presents differently than single-incident PTSD, the underlying mechanisms that ketamine targets (neuroplasticity, fear memory processing) are relevant across both presentations.
Ketamine therapy works best when it’s part of a broader treatment plan. Many clinicians recommend pairing ketamine sessions with psychotherapy to help process what comes up and integrate any shifts in perspective. At Pacific Mind Health, your team can help you think through what that looks like for your specific situation.
If you or someone you know is experiencing a mental health crisis, call or text 988. US military veterans can press 1 to be connected directly with the Veterans Crisis Line.
Frequently asked questions
Is ketamine FDA-approved for PTSD?
No. Ketamine is not FDA-approved for PTSD and is used off-label for this purpose. Off-label prescribing is legal and common in psychiatry when clinical evidence supports it. Spravato® (esketamine), a related medication, is FDA-approved for treatment-resistant depression and MDD with suicidal ideation — not for PTSD.
How many ketamine treatments are needed for PTSD?
The number of sessions varies depending on the individual and how they respond. Your provider will work with you to determine the right frequency and duration based on your response and overall treatment goals.
How does ketamine work differently than SSRIs for PTSD?
SSRIs target serotonin and typically take weeks to produce noticeable effects. Ketamine targets the glutamate system via NMDA receptor blockade, which promotes rapid neuroplasticity — the brain’s ability to form new connections.
Can ketamine help with complex PTSD (C-PTSD)?
Preliminary evidence and clinical experience suggest ketamine may be helpful for people with complex PTSD, which develops after prolonged or repeated trauma. A thorough psychiatric evaluation is needed to determine candidacy.
Can ketamine make PTSD worse?
For some people, the dissociative effects of ketamine can feel disorienting or, in rare cases, distressing, particularly if the dissociation triggers associations with prior trauma. This is why ketamine for PTSD is always administered in a supervised clinical setting with a care team present.
Looking for Spravato or ketamine treatment near you?
Pacific Mind Health offers Spravato (esketamine) and ketamine therapy for treatment-resistant depression, major depressive disorder, and more. Located in Southern California and serving patients across the state, Pacific Mind Health was founded by Joshua Flatow, MD, a board-certified psychiatrist and published peer-reviewed research author.
Ready to take the next step? Schedule a free consultation today to see if Spravato or ketamine is right for you.
